Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
First deaths recorded from Oropouche virus: PAHO calls for increased vigilance as virus spreads
arboviral, Europe, infection, Oropouche, PAHO, /in Arboviral Disease, E-News /by panglobalRecent deaths and potential vertical transmission prompt heightened concern over the midge- and mosquito-borne disease, as cases surge across the Americas and first cases are reported in Europe.
Long COVID: New review highlights scale and impact of persistent post-COVID condition
antiviral, infection, Long COVID, prevalence, prevention, /in COVID 19, E-News /by panglobalA comprehensive review of long COVID research reveals the widespread and potentially devastating effects of the condition, emphasising the urgent need for effective treatments and support systems.
Groundbreaking AI tool rivals expert sonographers in estimating gestational age
AI, gestational age, maternal care, pregnancy, ultrasound, /in AI, E-News, Ultrasound /by panglobalA new artificial intelligence-enabled ultrasound device allows novice users to estimate gestational age as accurately as trained sonographers, potentially revolutionising prenatal care in resource-limited settings.
Worm-inspired 3D printing breakthrough paves way for next-gen medical implants
3D printing, biomaterial, cardiac, cartilage, MedTech, /in E-News, MedTech /by panglobalResearchers at the University of Colorado Boulder and the University of Pennsylvania have developed a novel 3D printing technique that produces elastic, tough, and shapeable materials with potential applications in cardiac and cartilage repair.
New Alzheimer’s drugs may have limited population-level impact, researchers warn
Alzheimer’s, clinical trials, donanemab, efficacy, lecanemab, /in dementia, E-News, pharmacology /by panglobalCambridge scientists question whether recently approved amyloid immunotherapy treatments for Alzheimer’s disease will significantly reduce the condition’s burden, citing concerns about efficacy, safety, and health system challenges.
Brain-to-brain synchronicity reveals shared linguistic space during conversations
brains, communication, neuroscience, synchronise, verbal, /in E-News, Neurology /by panglobalA groundbreaking study from Princeton University has uncovered new insights into how our brains synchronise during verbal communication, demonstrating that specific words activate mirror patterns of brain activity in both speakers and listeners.
Diaphragm hibernation: New mechanism discovered in ICU patients on mechanical ventilation
diaphragm, ICU, myosins, Research, ventilation, /in E-News /by panglobalResearchers at Amsterdam University Medical Center have uncovered a novel mechanism explaining diaphragm weakness in mechanically ventilated intensive care patients, potentially paving the way for new treatments to aid ventilator weaning.
ChatGPT struggles with complex medical diagnoses, study finds
AI, ChatGPT, diagnostics, Research, /in AI, E-News /by panglobalA new study reveals that while ChatGPT shows promise in medical education, it falls short in diagnostic accuracy for complex clinical cases, raising concerns about its reliability as a standalone diagnostic tool.
New study reveals cannabis use during pregnancy more prevalent than previously thought – users need to be informed of risks
ADLM 2024, cannabis, foetus, pregnancy, Research, /in E-News, Reproduction /by panglobalA groundbreaking study presented at ADLM 2024 has uncovered alarming rates of cannabis use during pregnancy, highlighting the need for improved screening and patient education.
New cardiovascular risk equations could dramatically reduce statin and antihypertensive prescribing
cardiovascular disease, JAMA, PREVENT study, risk prediction, statins, /in Cardiovascular Disease, E-News /by panglobalA study published in JAMA estimates that adopting new cardiovascular disease risk prediction equations could make nearly 16 million fewer US adults eligible for preventive medications, potentially leading to over 100,000 additional occurrences of myocardial infarction or stroke over 10 years.